Finance

Lists
KLRS:NASDAQ
Kalaris Therapeutics Inc
၂.၂၃ US$
-၁.၃၃%
(-၀.၀၃၀) 1D
၂.၂၉ US$
+၂.၆၉% (+၀.၀၆၀)
After hours
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KLRS...
Open
၂.၂၇ US$
High
၂.၃၀ US$
Low
၂.၂၀ US$
Mkt. cap
၅.၃၁ ကုဋေ
Avg. vol.
၇.၇၂ သောင်း
Volume
၇.၃၃ သောင်း
52-wk high
၁၁.၈၈ US$
52-wk low
၂.၂၀ US$
EPS
-၂.၀၉ US$
Beta
၀.၄၂
Shares outstanding
၂.၃၈ ကုဋေ
No. of employees
၂၀
Open
၂.၂၇ US$
High
၂.၃၀ US$
Low
၂.၂၀ US$
Mkt. cap
၅.၃၁ ကုဋေ
Avg. vol.
၇.၇၂ သောင်း
Volume
၇.၃၃ သောင်း
52-wk high
၁၁.၈၈ US$
52-wk low
၂.၂၀ US$
EPS
-၂.၀၉ US$
Beta
၀.၄၂
Shares outstanding
၂.၃၈ ကုဋေ
No. of employees
၂၀
News stories
From web sources and news partners
BBN Times
BBN Times
·
ပြီးခဲ့သည့် ၁၀ မိနစ်
Nasdaq Today: Tech Index Falls to 27,204.38 on Chip Sell-Off and Bank Earnings Kickoff
Barchart.com
Barchart.com
·
ပြီးခဲ့သည့် ၄၁ မိနစ်
S&P 500: The 7,513 Low Held – Now in Wave Five, But I'm Watching 7,630
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ နာရီ
Dow Inc. (DOW) Rises As Market Takes a Dip: Key Facts
About Kalaris Therapeutics Inc
CEO-
Employees၂၀
Founded၂၀၁၉
HeadquartersBerkeley Heights, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to KLRS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for KLRS in the last 3 months.
Highest
Current ၂.၂၃ US$
၁၇.၀၀ US$ (+၆၆၂.၃၃%)
Average
၁၅.၅၀ US$ (+၅၉၅.၀၇%)
Lowest
၁၄.၀၀ US$ (+၅၂၇.၈၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Judah Frommer
Morgan Stanley
Buy
Reiterated
၁၄.၀၀ US$
+၅၂၇.၈%
08/12/2026
Yun Zhong
Wedbush
Buy
Reiterated
၁၇.၀၀ US$
+၆၆၂.၃%
08/11/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
08/11/2026
Tara Bancroft
TD Cowen
Buy
Initiated
-
-
06/15/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
၂၅.၀၀ US$
+၁,၀၂၁.၁%
05/13/2026
Biren Amin
Piper Sandler
Hold
Maintained
၇.၀၀ US$
+၂၁၃.၉%
03/30/2026
Daniil Gataulin
Chardan Capital
Buy
Initiated
၁၉.၀၀ US$
+၇၅၂%
12/23/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၉.၁၃ သန်း
၇.၁၆ သန်း
၇.၅၇ သန်း
၉.၀၂ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၆၂ သန်း
၃.၆၄ သန်း
၄.၂၆ သန်း
၃.၃၇ သန်း
Operating expense
၁.၂၇ ကုဋေ
၁.၀၈ ကုဋေ
၁.၁၈ ကုဋေ
၁.၂၄ ကုဋေ
Total operating expenses
၁.၂၇ ကုဋေ
၁.၀၈ ကုဋေ
၁.၁၈ ကုဋေ
၁.၂၄ ကုဋေ
Operating income
-၁.၂၇ ကုဋေ
-၁.၀၈ ကုဋေ
-၁.၁၈ ကုဋေ
-၁.၂၄ ကုဋေ
Other non operating income
၈.၄၇ သိန်း
၈.၀၃ သိန်း
၉.၇၇ သိန်း
၈.၇၁ သိန်း
EBT including unusual items
-၁.၁၉ ကုဋေ
-၁.၀၀ ကုဋေ
-၁.၀၉ ကုဋေ
-၁.၁၅ ကုဋေ
EBT excluding unusual items
-၁.၁၉ ကုဋေ
-၁.၀၀ ကုဋေ
-၁.၀၉ ကုဋေ
-၁.၁၅ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၁၉ ကုဋေ
-၁.၀၀ ကုဋေ
-၁.၀၉ ကုဋေ
-၁.၁၅ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၆၄
-၀.၄၄
-၀.၄၆
-၀.၄၈
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၂၇ ကုဋေ
-၁.၀၈ ကုဋေ
-၁.၁၈ ကုဋေ
-၁.၂၄ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ